| RS1657923690 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1657929865 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1657935515 |
FLAD1
|
Health Risk |
Likely pathogenic |
— |
| RS1657939192 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1657939866 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2 |
| RS1657940058 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1657950450 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1657955465 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1657961646 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1657965422 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Retinitis pigmentosa 39 |
| RS1657973895 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1657976025 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1657976232 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1657981723 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1657981991 |
PRPF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1657987278 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1657992030 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1657992342 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1657992486 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1657996197 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2A |
| RS1657997491 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1657997730 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1658036582 |
POGZ
|
Health Risk |
Likely pathogenic |
— |
| RS1658038847 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1658057278 |
PRPF3
|
Health Risk |
Likely pathogenic |
— |
| RS1658058398 |
CACNA1E
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS1658062720 |
PRPF3
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1658063448 |
PRPF3
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 18, Retinitis pigmentosa 18 |
| RS1658064113 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1658082808 |
PRPF3
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1658103320 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1658105150 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1658106325 |
CENPF
|
Health Risk |
Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS1658118461 |
H3-3A
|
Health Risk |
Likely pathogenic |
Bryant-Li-Bhoj neurodevelopmental syndrome 1, Bryant-Li-Bhoj neurodevelopmental syndrome 1 |
| RS1658119267 |
H3-3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Bryant-Li-Bhoj neurodevelopmental syndrome 1 |
| RS1658120232 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS1658121882 |
H3-3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Global developmental delay |
| RS1658149520 |
CACNA1E
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1658174717 |
CR2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS1658178709 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1658179729 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1658186071 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1658202227 |
RAB3GAP2
|
Health Risk |
Pathogenic |
Martsolf syndrome, Warburg micro syndrome 2 |
| RS1658215085 |
POMGNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS1658215662 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1658223688 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1658278935 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1658320297 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1658342879 |
SLC19A2
|
Health Risk |
Pathogenic |
Megaloblastic anemia, thiamine-responsive |
| RS1658344975 |
SLC19A2
|
Health Risk |
Pathogenic |
— |
| RS1658347337 |
REN
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 2, Familial juvenile hyperuricemic nephropathy type 2 |
| RS1658353874 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1658353990 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1658354243 |
SLC19A2
|
Health Risk |
Pathogenic |
— |
| RS1658356896 |
SLC19A2
|
Health Risk |
Likely pathogenic |
— |
| RS1658357615 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1658363329 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1658367194 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1658371275 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1658373672 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1658388636 |
CR2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS1658437185 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
RAB3GAP2-related disorder, RAB3GAP2-related disorder |
| RS1658476495 |
COQ8A
|
Health Risk |
Pathogenic |
— |
| RS1658479678 |
COQ8A
|
Health Risk |
Likely pathogenic |
Coenzyme Q10 deficiency, primary |
| RS1658539563 |
SLC19A2
|
Health Risk |
Pathogenic |
Sensorineural hearing loss disorder, Sensorineural hearing loss disorder |
| RS1658540031 |
SLC19A2
|
Health Risk |
Likely pathogenic |
— |
| RS1658552670 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1658562210 |
CR2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS1658577400 |
RAB3GAP2
|
Health Risk |
Pathogenic |
— |
| RS1658614059 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
Martsolf syndrome, Martsolf syndrome |
| RS1658637462 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS1658652635 |
CRB1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1658656722 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1658666393 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS1658671768 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1658673791 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1658684590 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1658688864 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1658689096 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1658690599 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1658691162 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1658692554 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1658697788 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS1658699227 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1658700284 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1658734768 |
TNNT2
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1658762654 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 69 |
| RS1658870968 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1658873227 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1658915833 |
NR3C1
|
Health Risk |
Pathogenic |
— |
| RS1658918693 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1658950895 |
LAMC2
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1658967336 |
RYR2
|
Health Risk |
Pathogenic |
Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1658971260 |
NRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, RASopathy |
| RS1658995249 |
ABCA4
|
Health Risk |
Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1659014112 |
GABRD
|
Health Risk |
Pathogenic |
Epilepsy, idiopathic generalized |
| RS1659051255 |
ABCA4
|
Health Risk |
Pathogenic |
ABCA4-related retinopathy, ABCA4-related retinopathy |
| RS1659061509 |
ABCA4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1659063174 |
COPA
|
Health Risk |
Pathogenic |
— |
| RS1659114692 |
PPOX
|
Health Risk |
Likely pathogenic |
— |